Lataa...
Infection risk in autoimmune hematological disorders with low‐dose rituximab treatment
BACKGROUND: Rituximab has been widely used in many autoimmune diseases. AIM: To evaluate the infection risk of rituximab in autoimmune hematological disorders. METHODS: Retrospectively studied and compared the clinical data of 89 patients in our hospital who used low‐dose rituximab (group R) or puls...
Tallennettuna:
| Julkaisussa: | J Clin Lab Anal |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7595891/ https://ncbi.nlm.nih.gov/pubmed/32794271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.23455 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|